Detection Autoantibody of Myasthenia Gravis

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Detection Autoantibody of Myasthenia Gravis trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

All recent trials (1 shown)

CompletedNot Applicable

NCT05219097

The Specificity, Sensitivity and Clinical Correlation of CBA, RIPA and ELISA in Detecting AChR and MuSK IgG of Myastheni…

Myasthenia gravis (MG) is a neuromuscular junction (NMJ) disorder mediated by autoantibodies against AChR, MuSK or other autoantigens located at the post synapt…

China2,663 participantsStarted 2021-01-01

Treatment: CBA Assay